Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Gang Zhao
    Professor
    Department of Pancreatic Surgery
    Huazhong University of Science and Technology
    China
    gangzhao@aliyun.com
    GJCT
    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina
    Greece
    ngrivas@cc.uoi.gr
    GJCT

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Prakash Paudyal
    Department of Pharmacology
    The University of Lowa
    USA
    ppaudyal2003@yahoo.com
    GJCT

    Research Interest: Role of GPCR signaling in cancer progression and metastasis.


    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Abdel-Moneim Osman
    Professor
    Department of Medicine
    King Abdel-Aziz University
    Saudi Arabia
    moneimosman@hotmail.com
    GJCT
    Research Interest: Cancer Research.Pharmacology, Cell Cycle Effect, Drug-Drug Intertaction, Chemoprotection, Potentiation olf Cytotoxic Drugs
    More Info.
    Mine Yarim
    Professor
    Yeditepe University
    Turkey
    myarim@yeditepe.edu.tr
    GJCT

    Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

    More Info.
    Andrey Akopov
    Professor
    Pavlov First State Medical University
    Russia
    akopovand@mail.ru
    GJCT

    Research Interest: Lung Cancer, Surgery, Neoadjuvant Therapy, Photodynamic Therapy, Targeted Therapy, Malignant Pleural Effusion, Endobronchial Therapy.


    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine
    India
    manzooriiim@gmail.com
    GJCT

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Varun Mittal
    Hematology and Oncology
    Albert Einstein Healthcare Network
    USA
    Varun.doc7@gmail.com
    GJCT

    Research Interest: Population Based Analysis of Cancer Database, Lung Carcinoma

    More Info.
    Vijai Kant Agnihotri
    Scientist
    Institute of Himalayan Bioresource Technology
    India
    kantvijai@yahoo.com
    GJCT

    Research Interest: Natural Product Chemistry, Toxicology, Spectroscopy, Essential Oils

    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Muzafar Ahmad Macha
    Department of Biochemistry
    Molecular Biology University Nebraska Medical Center
    USA
    muzafar.macha@unmc.edu
    GJCT

    Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    View more
    mendeley

    Nav channels in cancers: Non-classical roles

    DOI Logo 10.17352/2581-5407.000032

    Published On: October 15, 2020 | Pages: 028 - 032

    Author(s): Hengrui Liu*
    Abstract View Full Article View
    mendeley

    Experiences of women receiving high dose rate brachytherapy for cervical cancer at ocean road cancer institute Dar-es-salaam Tanzania

    DOI Logo 10.17352/2581-5407.000031

    Published On: August 18, 2020 | Pages: 023 - 027

    Author(s): Francis Kazoba* and Nazima Dharsee
    Abstract View Full Article View
    mendeley

    Efficacy of Neutron Radiotherapy for Primary Tracheal Adenoid Cystic Carcinoma: A Single Institution Retrospective Analysis

    DOI Logo 10.17352/2581-5407.000030

    Published On: May 22, 2020 | Pages: 015 - 022

    Author(s): Shilpen Patel*, Christine Y Chon, Laura Tedrick, Joshua K Calvert, Dean Lorimer, Justin R Shinn, Jing Zeng and George E Laramore
    Abstract View Full Article View
    mendeley

    Modern applications of cryosurgery in oncology

    DOI Logo 10.17352/2581-5407.000029

    Published On: May 19, 2020 | Pages: 010 - 014

    Author(s): Karthikeyan M*, Deepa MK*, Balasubramanian T, Monika Reji, Satish RC, Abhay AD, Shruti PC and Omkar SD
    Abstract View Full Article View
    mendeley

    Rare Case Botryoid Rhabdomyosarcomas of the Genital Tract. About a case in a 30-month-old child

    DOI Logo 10.17352/2581-5407.000028

    Published On: April 30, 2020 | Pages: 007 - 009

    Author(s): M Lahfaoui* and H Benhaddou
    Abstract View Full Article View
    mendeley

    FMTVDM-Breast Cancers Diagnostic Doorway from Qualitative to Quantitative Measurement, Care and Treatment

    DOI Logo 10.17352/2581-5407.000027

    Published On: April 13, 2020 | Pages: 004 - 006

    Author(s): Richard M Fleming*, Matthew R Fleming, William C Dooley
    Abstract View Full Article View
    mendeley

    A prospective for the role of two-pore channels in breast cancer cells

    DOI Logo 10.17352/2581-5407.000026

    Published On: March 30, 2020 | Pages: 001 - 003

    Author(s): Hengrui Liu*
    Abstract View Full Article View
    mendeley

    Contribution of viruses to cancer and its global burden

    DOI Logo 10.17352/2581-5407.000025

    Published On: August 20, 2019 | Pages: 012 - 015

    Author(s): Shahzeb Khan Shaz*
    Abstract View Full Article View
    mendeley

    A Novel Nutrient Mixture Induces Apoptosis in Human Mesothelioma Cells (MSTO-211H) via Activation of Caspases

    DOI Logo 10.17352/2581-5407.000024

    Published On: April 09, 2019 | Pages: 007 - 011

    Author(s): M Waheed Roomi, Bilwa Bhanap, Aleksandra Niedzwiecki* and Matthias Rath
    Abstract View Full Article View
    mendeley

    Synthesis of Some Aryl Ketoxime Derivatives with their in vitro Anti-microbial and Cytotoxic Activity

    DOI Logo 10.17352/gjct.000023

    Published On: March 08, 2019 | Pages: 001 - 006

    Author(s): Oguzhan Karaosmanoglu, Burcu Butun*, Hakan Dal, Hulya Sivas and Kadriye Benkli
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT